Neovasc’s Reducer Shows Promise For Refractory Angina
This article was originally published in The Gray Sheet
Executive Summary
In a small but sham-controlled trial Neovasc’s balloon-expandable implant significantly improved symptoms and quality of life in patients with refractory angina who are not candidates for other revascularization procedures. Reducer works by increasing pressure in the coronary sinus.
You may also be interested in...
Neovasc Sees Opportunities In Refractory Angina And Mitral Regurgitation Markets
Neovasc Inc. is targeting two highly underserved markets in cardiology – refractory angina and mitral valve disease – with unique transcatheter solutions. The angina device, called the Neovasc Reducer, is expected to enter the European market early next year.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.